Tryptase Level as a Marker of Complications in Transcatheter Aortic Valve Replacement
NCT03047681 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2017-02-09
Summary
An association between mast cells and outcomes of patients undergoing transcatheter aortic valve replacement (TAVR) has not been studied to our knowledge. We aim to characterize tryptase levels dynamics during TAVR; Demonstrate whether tryptase level post-TAVR can be used as a prognostic marker.
Conditions
- Transcatheter Aortic Valve Implantation Prosnosis and Complications
Interventions
- DIAGNOSTIC_TEST
-
venous blood withdrawl
patients will be asked for a venous blood sample
Sponsors & Collaborators
-
Tel-Aviv Sourasky Medical Center
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-02-28
- Primary Completion
- 2017-08-01
- Completion
- 2017-12-01
Countries
- Israel
Study Locations
More Related Trials
-
The Effect of the Forced Diuresis With Matched Hydration in Reducing Acute Kidney Injury During TAVI
NCT01866800 ·Status: COMPLETED ·Phase: PHASE4
-
Near INfrared Spectroscopy in Aortic valvE ReplacemenT
NCT01251328 ·Status: COMPLETED ·Phase: NA
-
Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial
NCT04310046 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Ischemic And Bleeding Risk Assessment After TAVR
NCT06000943 ·Status: RECRUITING
-
German Registry for Transcatheter Tricuspid Valve Interventions
NCT04653428 ·Status: RECRUITING
-
Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery
NCT02675244 ·Status: COMPLETED ·Phase: NA
-
Aortic Valve Replacement With Trifecta(TM)
NCT00475709 ·Status: COMPLETED ·Phase: NA
-
Patients With Severe TrIcuspid Regurgitation After triCvALve System Implantation
NCT05820516 ·Status: RECRUITING
-
Risk Stratification in Severe Treatment-naive, Tricuspid Regurgitation
NCT04173091 ·Status: UNKNOWN
-
TARGET 2.0 Study: Safety and Performance of the Cardiovalve TR Replacement System
NCT07334691 ·Status: RECRUITING ·Phase: NA
-
Fast Track Concept for Transfemoral TAVI
NCT04792827 ·Status: COMPLETED
-
Cardioprotective Effect of RIPC in Patients Undergoing TAVI
NCT02283398 ·Status: WITHDRAWN ·Phase: NA
-
SAfe and Fast Discharge With Acurate Valve in Low Risk tavI Patients
NCT05983458 ·Status: RECRUITING ·Phase: NA
-
Prophylactic Tricuspid Valve Annuloplasty in Patients Undergoing Mitral Valve Surgery
NCT01580436 ·Status: UNKNOWN ·Phase: NA
-
Aortic Valve Replacement With Trifecta(TM)
NCT00475267 ·Status: COMPLETED ·Phase: NA
-
MitraClip for Severe TR
NCT02863549 ·Status: UNKNOWN ·Phase: NA
-
Effect of Delayed Remote Ischemic Preconditioning on Myocardial Injury
NCT01903161 ·Status: COMPLETED ·Phase: NA
-
Assessments of Thrombus Formation in TAVI
NCT03248232 ·Status: COMPLETED
-
Protection by Remote Ischemic Preconditioning During Transcatheter Aortic Valve Implantation
NCT02080299 ·Status: UNKNOWN ·Phase: PHASE2
-
Early Safety and Clinical Efficacy of Mitral Allograft in Tricuspid Surgery
NCT06196684 ·Status: ACTIVE_NOT_RECRUITING
-
Hypothyroidism After the TAVI Procedure in Elderly Patients
NCT04831957 ·Status: RECRUITING ·Phase: NA
-
Outcomes of Transcatheter Aortic Valve Implantation in Oncology Patients With Severe Aortic Stenosis
NCT03181997 ·Status: COMPLETED
-
Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement
NCT01531374 ·Status: COMPLETED ·Phase: NA
-
Avr Thrombosis OutcoMe Study
NCT04234841 ·Status: NOT_YET_RECRUITING
-
Feasibility of Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic, Severe Aortic Stenosis
NCT02628899 ·Status: COMPLETED ·Phase: NA